VYRIPHARM Trademark

Trademark Overview


On Tuesday, January 19, 2021, a trademark application was filed for VYRIPHARM with the United States Patent and Trademark Office. The USPTO has given the VYRIPHARM trademark a serial number of 90474434. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 31, 2023. This trademark is owned by Vyripharm Enterprises LLC. The VYRIPHARM trademark is filed in the Pharmaceutical Products, Medical Instrument Products, and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical drugs for the treatment of neurological disorders, cancer oncology, diabetes, metabolic disease; pharmaceutical products for treatment of neurological disorders, cancer oncology, diabetes, metabolic disease; diagnostic preparations, namely, drugs for neurological disorders, cancer oncology, diabetes, metabolic disease for medical purposes; drug devices, namely, injectable intravenous and subcutaneous drug delivery devices filled with pharmaceutical drugs and drug preparations for neurological disorders, cancer oncology, diabetes, metabolic disease; drug delivery system comprising of patch and adhesive biodegradable membrane externally or internally that facilitate the delivery of a wide range of pharmaceuticals for the treatment of neurological disorders, cancer oncology, diabetes, metabolic disease and infectious diseases

Drug delivery systems, namely, gel patch or patch delivery system sold without medication, implantable drug delivery pumps, and drug delivery catheters

Pharmaceutical drug development services; Pharmaceutical research and development; Pharmaceutical products development and testing of pharmaceuticals; Compiling of data for pharmaceutical research purposes in the field of diagnostic and pharmaceutical drugs and raw materials for pharmaceutical drug development purposes
vyripharm

General Information


Serial Number90474434
Word MarkVYRIPHARM
Filing DateTuesday, January 19, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 31, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 1, 2022

Trademark Statements


Goods and ServicesPharmaceutical drugs for the treatment of neurological disorders, cancer oncology, diabetes, metabolic disease; pharmaceutical products for treatment of neurological disorders, cancer oncology, diabetes, metabolic disease; diagnostic preparations, namely, drugs for neurological disorders, cancer oncology, diabetes, metabolic disease for medical purposes; drug devices, namely, injectable intravenous and subcutaneous drug delivery devices filled with pharmaceutical drugs and drug preparations for neurological disorders, cancer oncology, diabetes, metabolic disease; drug delivery system comprising of patch and adhesive biodegradable membrane externally or internally that facilitate the delivery of a wide range of pharmaceuticals for the treatment of neurological disorders, cancer oncology, diabetes, metabolic disease and infectious diseases
Goods and ServicesDrug delivery systems, namely, gel patch or patch delivery system sold without medication, implantable drug delivery pumps, and drug delivery catheters
Goods and ServicesPharmaceutical drug development services; Pharmaceutical research and development; Pharmaceutical products development and testing of pharmaceuticals; Compiling of data for pharmaceutical research purposes in the field of diagnostic and pharmaceutical drugs and raw materials for pharmaceutical drug development purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 20, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, April 20, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, April 20, 2021
Primary Code042
First Use Anywhere DateSunday, September 28, 2014
First Use In Commerce DateSunday, September 28, 2014

Trademark Owner History


Party NameVyripharm Enterprises LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressHouston, TX 77021

Party NameVyripharm Enterprises LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressHouston, TX 77021

Trademark Events


Event DateEvent Description
Monday, July 31, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 31, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, December 27, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 1, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 1, 2022PUBLISHED FOR OPPOSITION
Wednesday, October 12, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, September 24, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 20, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 20, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 20, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, March 20, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, March 20, 2022NON-FINAL ACTION E-MAILED
Sunday, March 20, 2022NON-FINAL ACTION WRITTEN
Wednesday, March 9, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, March 9, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, March 9, 2022EXAMINERS AMENDMENT E-MAILED
Wednesday, March 9, 2022EXAMINERS AMENDMENT -WRITTEN
Friday, February 4, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 4, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 4, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 18, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 18, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, January 18, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, January 18, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 10, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 10, 2021NON-FINAL ACTION E-MAILED
Tuesday, August 10, 2021NON-FINAL ACTION WRITTEN
Saturday, July 31, 2021ASSIGNED TO EXAMINER
Tuesday, April 20, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 22, 2021NEW APPLICATION ENTERED